Therapeutic options for Bowen's disease

Gilberto Moreno; Alvin L K Chia; Adrian Lim; Stephen Shumack

doi:10.1111/j.1440-0960.2007.00317.x

Therapeutic options for Bowen's disease

Australas J Dermatol. 2007 Feb;48(1):1-8; quiz 9-10. doi: 10.1111/j.1440-0960.2007.00317.x.

Authors

Gilberto Moreno¹, Alvin L K Chia, Adrian Lim, Stephen Shumack

Affiliation

¹ St George Dermatology and Skin and Cancer Centre, Kogarah, New South Wales, Australia.

PMID: 17222293
DOI: 10.1111/j.1440-0960.2007.00317.x

Abstract

Multiple therapeutic options are available for treatment of Bowen's disease. The choice of therapy depends on clinical circumstance and medical practitioner experience. Newer therapies have more extensive support from the literature, but more established therapies may be preferred because of accessibility, cost and efficacy. An overview of the current therapeutic options for Bowen's disease is presented.

Publication types

Review

MeSH terms

Aminoquinolines / therapeutic use
Antineoplastic Agents / therapeutic use
Bowen's Disease / drug therapy*
Bowen's Disease / pathology
Bowen's Disease / surgery*
Cautery
Cryotherapy
Fluorouracil / therapeutic use
Humans
Imiquimod
Photochemotherapy
Photosensitizing Agents / therapeutic use
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology
Skin Neoplasms / surgery*

Substances

Aminoquinolines
Antineoplastic Agents
Photosensitizing Agents
Imiquimod
Fluorouracil